DXS International plc (AQSE: DXSP): Half-year Financial Report

Summary by AI BETAClose X

DXS International plc reported a decrease in revenue to £1,684,712 for the half-year ending 31 October 2025, down 2.6% from £1,730,829 in the prior year period, and incurred a loss after tax of (£99,041) compared to a profit of £1,131, primarily due to a reduction in Grant Income. Despite this, available cash increased to £160,400, and the company highlighted positive feedback on its new SMART Referral solution, progress on its Secondary Care pilot, and the imminent market readiness of its Cholesterol prototype, which targets significant NHS incentives. The company anticipates revenue growth around April 2026 and remains confident in meeting full-year market expectations for April FY 2026.

Disclaimer*

UK 100

Latest directors dealings